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Breeding Restrictions Decrease the Prevalence of Myxomatous
Mitral Valve Disease in Cavalier King Charles Spaniels over an
8- to 10-Year Period
A.C. Birkegard, M.J. Reimann, T. Martinussen, J. H€aggstr€om, H.D. Pedersen, and L.H. Olsen
Background: Cavalier King Charles Spaniels (CKCS) are predisposed to myxomatous mitral valve disease (MMVD).
Studies have indicated a strong genetic background.
Objective: The aim of this study was to evaluate the effect of a breeding scheme involving auscultation and echocardiog-
raphy.
Animals: In the Danish Kennel Club mandatory breeding scheme, 997 purebred CKCS were examined during the period
2002–2011. Each dog was evaluated 1–4 times with a total of 1,380 examinations.
Methods: Auscultation and echocardiography were performed to evaluate mitral regurgitation murmur severity and
degree of mitral valve prolapse (MVP). The odds of having mitral regurgitation murmur or MVP > grade 1 in 2010–2011
compared to 2002–2003 were estimated using logistic regression analysis including age and sex as covariates. Odds were esti-
mated for dogs that were products of the breeding scheme (defined as dogs with both parents approved by the breeding
scheme before breeding) and non-products of the breeding scheme (defined as dogs with at least 1 parent with unknown
cardiac status).
Results: In 2010–2011, the odds of having mitral regurgitation murmur were 0.27 if dogs were a product of the breeding
scheme compared with dogs in 2002–2003, reflecting a 73% decreased risk (P < .0001). If non-products of the breeding
scheme examined in 2010–2011 were compared with dogs in 2002–2003, no difference in odds was found (P = .49).
Conclusion and Clinical Importance: A mandatory breeding scheme based on auscultation and echocardiography findings
significantly decreased the prevalence of MMVD over the 8- to 10-year period. Such a breeding scheme therefore is recom-
mended for CKCS.
Key words: Dog; Genetics; Inheritance; Mitral valve prolapse.
Myxomatous mitral valve disease (MMVD) oftencauses cardiac-related death in dogs <10 years of
age.1 The disease results in valvular extracellular matrix
changes including deposition of mucopolysaccarides
and collagen degeneration.2 The valvular changes may
cause mitral valve prolapse (MVP) and insufficient clo-
sure of the mitral valve leading to mitral regurgitation.2
Mitral regurgitation murmur intensity and echocardio-
graphic MVP are predictors of MMVD progression in
dogs.3–5 The disease is most common in small and med-
ium-sized dog breeds, but often is a relatively benign
condition because of its slow disease progression.5,6 A
higher prevalence and earlier onset of the disease have
been reported in Cavalier King Charles Spaniels
(CKCS) compared to other dog breeds.1,3,7 A study
from Sweden based on animal insurance data from
1995 to 2006 shows that the disease accounts for 37%
of the total mortality among CKCS <10 years of age.1
Hereditary background of MMVD has long been
suggested on the basis of a higher prevalence of the dis-
ease in certain dog breeds,2 and more recent studies
indicate strong genetic background with polygenic
inheritance.8,9 In CKCS, a positive association between
parental heart status and mitral regurgitation murmur
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intensity in 5 year-old offspring has been reported.8
Furthermore, in Dachshunds, a positive association has
been found between the degree of MVP in parents and
offspring.9 Based on data from the United Kingdom, a
high heritability for MMVD in CKCS has been esti-
mated.10 The heritability for having a mitral regurgita-
tion murmur and for the grade of murmur intensity was
estimated to 0.33 and 0.67, respectively.10 Furthermore,
a recent genome-wide association study found 2 gene
loci on chromosomes 13 and 14 that differ between
CKCS with early and late onset of MMVD.11 However,
another similar genome-wide association study includ-
ing a lower number of CKCS did not find any associa-
tion between gene loci and MMVD disease severity.12
Additional studies are needed to further elucidate asso-
ciations between gene changes and MMVD disease
severity.
Breeding restrictions or recommendations aimed at
decreasing the prevalence of MMVD in CKCS have
been developed in breeding clubs in different countries.
The high heritability of the disease indicates that selec-
tion against the disease could be successful.10 From
2001, a breeding scheme has been ongoing in Denmark
as a collaboration between the Danish Kennel Club
Association (DKCA), The Cavalier Club in Denmark
and the University of Copenhagen. The aim of this-
study was to evaluate if a mandatory breeding scheme
based on echocardiography and cardiac auscultation
results in decreased MMVD severity in CKCS after an
8- to 10-year time period.
Materials and Methods
Study Design
A retrospective study of the mandatory cardiac examinations
in the DKCA breeding scheme was performed. Inclusion criteria
for the statistical analyses were that the cardiac examinations
were performed in the period 2002–2011 (both years included),
all data from the individual examination were available, and that
the dogs were registered in DKCA. Dogs had to be at least
1.5 years at the first examination and registered in the DKCA
with a verified CKCS pedigree. Pregnant and lactating dogs were
excluded.
Cardiac Examination and Observers
Cardiac auscultation was performed and the degree of mitral
regurgitation murmur was graded from 1 to 6.13 The echocardio-
graphic degree of MVP was evaluated with the dog placed in right
lateral recumbency using a right parastenal long axis 4-chamber
echocardiographic view with focus on the mitral valve.14,15
Echocardiographic recordings were stored on video tape or digi-
tally on DVD. Auscultation and echocardiography were performed
by 1 of 8 veterinarians (clinical observers; Table 1). Five clinical
observers were general practitioners with cardiovascular interest
selected by University of Copenhagen, trained at least 2 days in
cardiac auscultation and MVP echocardiography and approved by
the founder of the breeding scheme (HDP) in 2001 at University
of Copenhagen. Two cardiovascular researchers (LHO and JK)
with at least 8 years small animal cardiovascular clinical research
experience were included as clinical observers in 2004 and 2009,
respectively.
Echocardiographic Assessment of MVP
The degree of MVP was evaluated by LHO or HDP (MVP
observers). The degree of MVP was assessed as 0 (≤1.5 mm as the
sum of the maximum protrusion of the cranial, caudal and coap-
tion point of the mitral valve according to annulus plane), 1 (>1.5
and ≤4.5 mm), 2 (>4.5 and ≤7.5 mm), and 3 (>7.5 mm).14–16 One
of the MVP observers (HDP) evaluated the MVP echocardiograms
from the debut of the breeding scheme until November 2004, here-
after the recordings were evaluated by the other MVP observer
(LHO). The MVP observers made the final approval for the
DKCA report (see below).
Breeding Guidelines and Cardiac Health Criteria
Dogs examined ≥1½ years of age were approved for breeding
until 4 years of age if cardiac health criteria were fulfilled. To con-
tinue breeding in DKCS after 4 years of age dogs had to be reex-
amined. From January 2007, an additional restriction was decided
introducing an additional reexamination after 6 years of age for
male dogs. At all examination time points, dogs were excluded
from breeding if they had MVP grade 3 (first a criterion from
2007) or a mitral regurgitation murmur grade ≥3. Dogs with grade
2 murmurs were excluded if they had MVP grades 2 or 3. Thus,
cardiac health criteria for breeding in the MMVD breeding scheme
of the DKCA were as follows: Mitral regurgitation murmur of 1
at a maximum combined with a MVP grade 2 at a maximum; or a
grade 2 murmur combined with a degree of MVP not >1. Before
2007, dogs with a grade 3 MVP were approved if they had a mur-
mur grade not >1. Ejection murmurs (physiological flow murmurs)
were accepted. They were diagnosed as systolic murmurs with
crescendo–decresendo sound configuration, point of maximal
intensity at the left heart base and with minimal or no concurrent
mitral regurgitation estimated using color flow Doppler echocar-
diography.17 These dogs often have aortic flow maximum velocity
on the higher side of the normal reference range (>1.5 m/s).18 This
observation was used to confirm the diagnosis. Dogs with heart
murmurs caused by non-MMVD cardiac disease were excluded.
Mitral regurgitation murmur intensity and MVP status of all
examined dogs became freely available from DKCA homepage
after examination. Each parent needed to fulfill the cardiac health
criteria for registration of their puppies in DKCA.
Statistics
All statistical calculations were conducted with a statistical soft-
ware program (SAS)a and a statistical significance level of 5% was
used.
Logistic regression analysis taking clustering caused by multiple
measurements per clinical observer into account was performed
using proc genmod in the SAS system. Dogs examined in the years
of 2002, 2003, 2010, and 2011 were divided into 3 groups. Group
1 was defined as all dogs examined in 2002 and 2003. Dogs in
group 2 were examined in 2010 and 2011, and in addition, were a
product of the breeding scheme (PB). Group 3 consisted of dogs
also examined in 2010 and 2011 but not a product of the breeding
scheme (non-PB). Products of the breeding scheme were defined as
dogs with both parents approved by the DKCA breeding scheme.
Only the most recent examination was included in the statistical
analyses if a dog had repeated examinations within the time per-
iod. The presence of mitral regurgitation murmur (yes/no) or
degree of MVP > 1 (yes/no) were included as response variables
and age at examination, group (1, 2 or 3) and sex (male or female)
were included as explanatory variables. Backward stepwise elimi-
nation was performed until only explanatory variables showing
significance were left in the model. If an overall significance of
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group was found, the risk of having a mitral regurgitation murmur
or MVP > 1 was compared between group 1 (all dogs examined in
2002 and 2003) and group 2 (PB examined in 2010 and 2011),
group 1 and group 3 (non-PB examined in 2010 and 2011), and
finally group 2 and 3, to evaluate a potential effect of the MMVD
breeding scheme.
Results
A total of 1,471 cardiac examinations were performed
from the debut of the DKCA breeding scheme in
December 2001 until the end of 2011. Ninety-one car-
diac examinations were excluded from the statistical
analyses according to predefined criteria (Fig 1). A total
of 1,380 cardiac examinations were included from 2002
to 2011 (Tables 1 and 2). In the period, 997 dogs were
evaluated (689 females and 308 males). Dogs of both
sexes were evaluated 1–4 times with an average of 1.4
Table 1. Number of dogs examined by 8 different clinical observers from 2002 to 2011 in the Danish Kennel Club
Association (DKCA) myxomatous mitral valve disease (MMVD) breeding scheme.
Clinical







2002 64 0 0 8 19 29 12 1 133 11 8.3
2003 57 1 0 6 6 17 10 2 99 5 5.1
2004 34 18 0 7 2 24 9 1 95 3 3.2
2005 0 79 0 10 4 16 7 2 118 4 3.4
2006 1 79 0 10 1 24 5 2 122 6 4.9
2007 0 91 0 6 6 31 15 5 154 17 11.0
2008 0 124 0 8 7 21 7 3 170 10 5.9
2009 0 117 2 7 4 15 6 8 159 5 3.1
2010 0 131 1 2 3 8 11 7 163 8 4.9
2011 0 123 3 9 5 16 8 3 167 9 5.4
Total 156 763 6 73 57 201 90 34 1,380 78 5.7
Table 2. Characteristics of the dogs examined from
2002 to 2011 in the Danish Kennel Club Association
(DKCA) myxomatous mitral valve disease (MMVD)








n 215 172 153
Age (years) 2.5 (1.8–4.4) 2.0 (1.7–4.1) 2.3 (1.6–4.4)
Sex (m/f) 63/152 54/118 63/90
Only the most recent examination was included in the statistical
analyses if dogs had repeated examinations. Group 1 is dogs
examined in 2002 and 2003. Group 2 and 3 are dogs examined in
2010 and 2011 that are products of the breeding scheme (PB) and
nonproducts of the breeding scheme (non-PB), respectively. f,
female; m, male. Except for sex, data are shown as median and 25
and 75% interquartile intervals.
Fig 1. Flowchart for the study.
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evaluations per dog. Presence of heart murmur could
not be evaluated satisfactorily in 5 dogs and therefore
their results regarding murmur were removed from the
statistical analyses. Among the 1,380 cardiac examina-
tions, 137 mitral regurgitation murmurs (10%), 83 inno-
cent flow murmurs (6%) and 84 MVP grade 3 (6%)
were found. In total, 78 dogs (5.7%; 39 males and 39
females) were excluded from breeding (31 males and 18
females from 2007 to 2011). Among dogs with repeated
examinations (n = 343 [306 dogs twice, 34 dogs 3 times
and 3 dogs 4 times]), 6 dogs (2%) had decreased degree
of mitral regurgitation murmur of 1 grade and 11 dogs
(3%) had decreased MVP of 1 grade over time.
Reduction in Risk of Having a Mitral Regurgitation
Murmur
Group and age statistically significantly influenced
the presence of mitral regurgitation murmur (Table 3).
The odds of having mitral regurgitation murmur in
2010–2011 compared to 2002–2003 were 0.27 if the dogs
in 2010–2011 were PB, reflecting a 73% decreased risk
(P < .0001; Table 3 and Fig 2). Similarly, within 2010–
2011, the odds of having mitral regurgitation murmur
for dogs that was PB was 0.31 compared to non-PB,
reflecting 69% decreased risk (P < .0001). If non-PB
examined in 2010–2011 were compared with dogs exam-
ined in 2002–2003, no statistical difference in odds of
having mitral regurgitation murmur was found
(P = .4873). There was no significant influence of sex
on odds of murmur. Odds of having a murmur were
higher with advancing age (P < .0001; Table 3).
Reduction in Risk of Having MVP > 1
Group, sex, and age at examination significantly
influenced the presence of MVP above grade 1
(Table 3). In 2010–2011, the odds of PB having
MVP > 1 compared to non-PB was 0.64 reflecting a
36% reduced risk (P < .0006; Table 3 and Fig 3). There
was no significant difference in odds of having
MVP > 1 in 2010–2011 compared with 2002–2003.
Discussion
Our study shows that a breeding scheme based on
cardiac auscultation and echocardiography markedly
decreased the risk of having a mitral regurgitation mur-
mur caused by MMVD after an 8- to 10-year period.
The reduction in risk was only significant for offspring
where both parents had been approved by the breeding
scheme (PB), not for offspring where 1 or both parents
not were approved by the breeding scheme (non-PB).
The risk of having moderate to severe MVP (MVP > 1)
was not decreased after the 8- to 10-year period, but PB
had lower risk of MVP > 1 than did non-PB within the
years 2010 and 2011.
To the authors’ knowledge ours is the first study
reporting a clear effect of a breeding scheme aimed at
decreasing the prevalence of MMVD in CKCS (or in
any breed). Preliminary findings from the British volun-
tary breeding scheme (annual cardiac auscultation and
parents’ murmur status) reported an effect in the group
of dogs auscultated by a general practitioner but only a
trend was reported when the dogs were auscultated by
a veterinary cardiologist.19 A mandatory breeding
scheme in Sweden including annual cardiac auscultation
and parent information did not result in significant
effect of the scheme, albeit after a short follow-up per-
iod (2007–2009).20
Different breeding schemes aimed at decreasing the
prevalence of MMVD in CKCS are ongoing in several
countries worldwide to guide dog breeders.19 The breed-
ing schemes are mandatory or voluntary, include car-
diac auscultation or both cardiac auscultation and
echocardiography and some programs include parent
cardiac information. Some schemes include annual car-
diac examinations where as others have a more limited
number of cardiac examinations during the dog’s life-
time. In some schemes, the cardiac examination results
are open to the public, in others the results are only
known by the dog owner. How much such factors influ-
ence the effect of a breeding scheme still needs much
clarification.
Voluntary participation may decrease the number of
dog owners who follow the breeding advice and thereby
Table 3. Odds for occurrence of mitral regurgitation murmur and moderate to severe mitral valve prolapse (MVP)







(Group 2 Versus Group 1)
Non-PB 2010–2011
Versus 2002–2003
(Group 3 Versus Group 1)
PB Versus Non-PB 2010–2011
(Group 2 Versus Group 3)
MR murmur > 0 Agea at examination
(P < .0001)
P <.0001 .49 <.0001
OR 0.27 – 0.31
95% 0.16–0.43 – 0.24–0.41
MVP > 1 Agea at examination
and sexb
(both P < .0001)
P .23 .78 .0006
OR – – 0.64
95% – – 0.49–0.82
Group 1 is dogs examined in 2002 and 2003. Group 2 and 3 are dogs examined in 2010 and 2011 that are products of the breeding
scheme (PB) and nonproducts of the breeding scheme (non-PB), respectively. MR, mitral regurgitation. OR, odds ratio; 95%, 95% confi-
dence interval for the odds ratio.
aOdds increase with advancing age.
bMale higher odds than female.
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decrease the effect of a breeding scheme. In a subanaly-
sis of the voluntary British breeding scheme, it became
evident that only 4% of the dog owners had followed
the breeding advice.21 Number of included observers
and observer experience also may influence the effect of
breeding schemes because observer variations are well-
known with regard to cardiac auscultation and echocar-
diography.14,17 Therefore interobserver variation was
taken into account in the statistical analyses in this
study. Unexpected reduction over time in individual
mitral regurgitation murmur intensity or degree of
MVP was observed in only a few dogs with repeated
examinations. The reductions may be the result of chan-
ged physiological conditions in the dog such as changed
body condition, heart rate, or both.9,17
Color flow Doppler echocardiography can confirm the
diagnosis of mitral regurgitation, but experienced obser-
vers can detect mitral regurgitation using auscultation in
89% of dogs with mild or more severe mitral regurgita-
tion (regurgitant jet area >30% of the left atrial area).17
Moderately, experienced observers (general practitioners
level) can detect mitral regurgitation in 72% of the dogs
by auscultation. Echocardiography is useful to support
the diagnosis of ejection murmurs (physiological flow
murmurs) and other heart murmurs not associated with
mitral regurgitation.17 In this study, approximately 6%
of the dogs examined from 2002 to 2011 were diagnosed
with ejection murmurs based on clinical findings and
echocardiography. In a previous study, 6 of 57 (10%)
CKCS were diagnosed with ejection murmurs based on
auscultation and phonography.17 Ejection murmurs do
not seem to be associated with heart disease,17,18 and
exclusion of dogs with ejection murmurs in breeding
schemes may unnecessarily decrease the number of
CKCS available for breeding. Estimation of mitral regur-
gitant jet size in relation to left atrial area using color
flow Doppler echocardiography is a semi-quantitative
estimate influenced by several factors including echocar-
diographic equipment and technical settings.22 This limi-
tation may affect the use of this method in breeding
schemes including multicenter clinical examinations.
Studies have shown that MVP is an early predictor
of MMVD disease progression and is correlated with
other disease variables such as degree of mitral regurgi-
tation and mitral valve thickness.4,5 In this study, the
risk of having moderate to severe MVP was not found
to be decrease in the breeding scheme during the 8- to
10-year follow-up period. However in 2010 and 2011,
PB were found to have a decreased risk of having mod-
erate to severe MVP compared to non-PB suggesting an
effect of the breeding scheme on this parameter as well.
The study has limitations. One of the observers in the
breeding scheme was replaced in 2004 and the overall
observer performance may have changed during the 8-
to 10-year time period. Clinical observer was included as
random variable in the statistical models to take obser-
ver variation into account. However, it was not possible
to include MVP observer variation in the modeling. Yet,
the finding of a decreased risk of MMVD was confirmed
by comparison of the risk of having a mitral regurgita-
tion murmur and moderate to severe MVP (MVP > 1)
within a limited time period (2010–2011) between PB
and non-PB during a period with no observer replace-
ments. Finally, it is a study limitation that observers
were not blinded to the identity of the dogs.
Further evaluations of breeding schemes are recom-
mended to identify factors with major influence on the
effect of such schemes. Echocardiography and manda-
tory registrations are time-consuming. Therefore, fur-
ther evaluation of ongoing breeding schemes is
necessary to find the scheme with the highest cost bene-
fit. Until now, the present DKCA breeding scheme is
the only scheme with a documented effect. This pro-
Fig 2. Mitral regurgitation murmur intensity (grade 1–6) in dogs
examined in the Danish Kennel Club Association (DKCA) myxo-
matous mitral valve disease (MMVD) breeding scheme in 2002–
2003 and 2010–2011. The Y axis indicates the percentage of dogs
with different degrees of mitral regurgitation murmur among dogs
examined within the time period. Only the most recent examina-
tion is included in the figure if dogs had repeated examinations.
PB, products of the breeding scheme. Non-PB, nonproducts of the
breeding scheme.
Fig 3. Degree of mitral valve prolapse (MVP) (grade 0–3) in dogs
examined in the Danish Kennel Club Association (DKCA) myxo-
matous mitral valve disease (MMVD) breeding scheme in
2002–2003 and 2010–2011. The Y axis indicates the percentage of
dogs with different degrees of MVP among dogs examined within
the time period. Only the most recent examination is included in the
figure if dogs had repeated examinations. PB, products of the breed-
ing scheme. Non-PB, nonproducts of the breeding scheme.
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gram is recommended until other breeding schemes
aimed at decreasing the prevalence of MMVD with
higher performance are described. Genetic tests poten-
tially could be included in future breeding schemes.
In conclusion, a mandatory breeding scheme based
on auscultation and echocardiography significantly
decreased the prevalence of MMVD over the 8- to 10-
year time period. Therefore, such a breeding scheme is
recommended for CKCS.
Footnote
a SAS statistical software, version 9.3, SAS Institute A/S, Cary,
NC
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